H.C. Wainwright's valuation of Microbot Medical (NASDAQ:MBOT) stands at an estimated market value of $255 million, or $9 per share, which underpins the revised price target. The current market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback